Description
The U.S. Food and Drug Administration (FDA) is seeking capability statements from small business sources to replace existing motor control centers (MCCs), switchgear equipment, and draw-out breakers in Bldg. 62 of the FDA facility in Jefferson, Arkansas. The project involves replacing antiquated commercial electrical equipment, conducting arc-flash studies and thermal scanning, and testing new breakers. Interested firms must submit capability statements via email by April 21, 2026. The statements should include business information, past performance, descriptive literature, and other relevant details.
• The replacement of MCCs, switchgear equipment, and draw-out breakers is the primary scope of work.
• The project is located at the National Center for Toxicological Research (NCTR) in Jefferson, Arkansas.
• The estimated period of performance is 24 months after official Notice to Proceed.
• Capability statements should include business name and bio, Unique Entity ID, business address, and other relevant information.
• Past performance information for similar projects should be included, if applicable.